Published in J Pharmacol Exp Ther on November 01, 1997
Pathobiology of dynorphins in trauma and disease. Front Biosci (2005) 1.17
Decoy peptides that bind dynorphin noncovalently prevent NMDA receptor-mediated neurotoxicity. J Proteome Res (2006) 0.88
NMDA receptors in the basal ganglia. J Anat (2000) 0.80
Local inhibitory effects of dynorphin A-(1-17) on capsaicin-induced thermal allodynia in rhesus monkeys. Eur J Pharmacol (2000) 0.78
Paradoxical hyperalgesia induced by mu-opioid receptor agonist endomorphin-2, but not endomorphin-1, microinjected into the centromedial amygdala of the rat. Eur J Pharmacol (2006) 0.75
The synthesis and opiate activity of beta-endorphin. Biochem Biophys Res Commun (1976) 1.46
Rat vas deferens: a specific bioassay for endogenous opioid peptides. Br J Pharmacol (1978) 1.24
The single mutation Trp35-->Ala in the 35-40 redox site of Chlamydomonas reinhardtii thioredoxin h affects its biochemical activity and the pH dependence of C36-C39 1H-13C NMR. Eur J Biochem (1998) 1.14
Chromaffin cell scinderin, a novel calcium-dependent actin filament-severing protein. EMBO J (1990) 1.08
Glutathione is implied in the control of 7-ketocholesterol-induced apoptosis, which is associated with radical oxygen species production. FASEB J (1998) 1.03
Studies on the inhibitory action of opiate compounds in isolated bovine adrenal chromaffin cells: noninvolvement of stereospecific opiate binding sites. J Neurochem (1981) 1.03
Quality of life in multiple sclerosis: influence of interferon-beta1 a (Avonex) treatment. Mult Scler (2002) 1.00
Possible muscarinic regulation of catecholamine secretion mediated by cyclic GMP in isolated bovine adrenal chromaffin cells. Biochem Pharmacol (1981) 0.99
Pharmacological manipulation of Ins(1,4,5)P3 signaling mimics preconditioning in rabbit heart. Am J Physiol (1999) 0.98
Systemic administration of beta-endorphin: potent hypotensive effect involving a serotonergic pathway. Proc Natl Acad Sci U S A (1978) 0.97
Ca2+ currents in compensated hypertrophy and heart failure. Cardiovasc Res (1998) 0.96
Cysteine-153 is required for redox regulation of pea chloroplast fructose-1,6-bisphosphatase. FEBS Lett (1997) 0.95
Hepatic acute phase induction of murine beta-galactoside alpha 2,6 sialyltransferase (ST6Gal I) is IL-6 dependent and mediated by elevation of exon H-containing class of transcripts. Glycobiology (1999) 0.95
Target-controlled infusion of propofol and remifentanil in cardiac anaesthesia: influence of age on predicted effect-site concentrations. Br J Anaesth (2003) 0.94
Adenohypophyseal secretory granules. I. Their phosphorylation and association with protein kinase. J Biol Chem (1971) 0.94
Synthesis and biological activity of camel and bovine beta-melanotropins. J Med Chem (1976) 0.94
Total synthesis of camel beta-melanotropin by the solid-phase method. Biochemistry (1975) 0.94
Cloning and expression of human 5-HT4S receptors. Effect of receptor density on their coupling to adenylyl cyclase. Neuroreport (1997) 0.92
Early evaluation of dressage ability in different breeds. Equine Vet J Suppl (2002) 0.91
Dynorphin-(1-13). I. Structure-function relationships of Ala-containing analogs. Int J Pept Protein Res (1984) 0.91
Ceramide generation occurring during 7beta-hydroxycholesterol- and 7-ketocholesterol-induced apoptosis is caspase independent and is not required to trigger cell death. Cell Death Differ (2001) 0.90
Rapid rise in cyclic GMP accompanies catecholamine secretion in suspensions of isolated adrenal chromaffin cells. Life Sci (1979) 0.90
Adenosine 3',5'-monophosphate-dependent protein kinase from bovine anterior pituitary gland. II. Subcellular distribution. J Biol Chem (1971) 0.89
Non-opioid effects of dynorphins: possible role of the NMDA receptor. Trends Pharmacol Sci (1994) 0.89
Induction of apoptosis and of interleukin-1beta secretion by 7beta-hydroxycholesterol and 7-ketocholesterol: partial inhibition by Bcl-2 overexpression. FEBS Lett (1997) 0.87
Adrenocorticotropin. 51. Synthesis and properties of analogues of the human hormone with tyrosine residues replaced by 3,5-diiodotyrosine. J Am Chem Soc (1977) 0.86
Phosphorylation of adenohypophyseal plasma membranes and properties of associated protein kinase. J Biol Chem (1974) 0.86
Interaction of thioredoxins with target proteins: role of particular structural elements and electrostatic properties of thioredoxins in their interplay with 2-oxoacid dehydrogenase complexes. Protein Sci (1999) 0.85
The internal Cys-207 of sorghum leaf NADP-malate dehydrogenase can form mixed disulphides with thioredoxin. FEBS Lett (1999) 0.85
Dynorphin and enkephalins in adrenal paraneurones. Opiates in the adrenal medulla. Can J Physiol Pharmacol (1984) 0.84
Characterization of the high affinity [3H]nociceptin binding site in membrane preparations of rat heart: correlations with the non-opioid dynorphin binding site. J Mol Cell Cardiol (1998) 0.83
Evidence that inhibition of nicotine-mediated catecholamine secretion from adrenal chromaffin cells by enkephalin, beta-endorphin, dynorphin (1-13), and opiates is not mediated via specific opiate receptors. J Neurochem (1982) 0.83
High-level expression of recombinant pea chloroplast fructose-1,6-bisphosphatase and mutagenesis of its regulatory site. Eur J Biochem (1995) 0.83
Pulmonary bombesin in experimentally induced asbestosis in rats. Exp Lung Res (1985) 0.83
Pharmacodynamic evaluation of the activity of antibiotics against hemin- and menadione-dependent small-colony variants of Staphylococcus aureus in models of extracellular (broth) and intracellular (THP-1 monocytes) infections. Antimicrob Agents Chemother (2012) 0.83
N-methyl-D-aspartate receptor antagonist activity and phencyclidine-like behavioral effects of the pentadecapeptide, [Ser1]histogranin. Pharmacol Biochem Behav (1995) 0.82
Increased preproenkephalin A gene expression in the rat heart after induction of a myocardial infarction. Biochem Cell Biol (1992) 0.81
Studies on the inhibitory action of somatostatin in the electrically stimulated rat vas deferens. Eur J Pharmacol (1979) 0.81
Interactions of histogranin and related peptides with dopamine D2 receptor in rat brain membranes. Synapse (2001) 0.81
Opioid receptors in bovine adrenal medulla. Can J Physiol Pharmacol (1984) 0.81
Thyrotropin-releasing hormone receptor: Its partial purification from bovine anterior pituitary gland and its close association with adenyl cyclase. FEBS Lett (1972) 0.80
Synthesis and biological activity of monothionated analogs of leucine-enkephalin. Int J Pept Protein Res (1984) 0.80
Adenosine-3',5'-monophosphate-dependent protein kinase from bovine anterior pituitary gland. 3. Structural specificity of the ATP site of the catalytic subunit. Can J Biochem (1974) 0.80
Role of cyclic AMP in the action of hypothalamic regulatory hormones. Adv Cyclic Nucleotide Res (1975) 0.80
Dynorphin in bovine adrenal medulla. II. Isolation, partial characterization and biological activity of two distinct molecules. Int J Pept Protein Res (1982) 0.80
Interaction of dynorphin with kappa opioid receptors in bovine adrenal medulla. Neuropeptides (1985) 0.79
Adenosine 3',5'-monophosphate-dependent protein kinase from bovine anterior pituitary gland. I. Properties. J Biol Chem (1971) 0.79
Comparative spinal analgesic action of dynorphin1-8, dynorphin1-13, and a kappa-receptor agonist U50,488. Can J Physiol Pharmacol (1986) 0.79
Asbestos-related increase in pulmonary levels of vasoactive intestinal peptide (VIP). Life Sci (1983) 0.79
Interaction of 1,3-di(2-[5-3H]tolyl) guanidine with sigma 2 binding sites in rat heart membrane preparations. Eur J Pharmacol (1991) 0.79
Synthesis and biological activity of beta-endorphin and analogues. Additional evidence for multiple opiate receptors. J Med Chem (1978) 0.79
Distinct regulations by calcium of cyclic GMP levels and catecholamine secretion in isolated bovine adrenal chromaffin cells. Metabolism (1981) 0.78
Up-regulation of cytokine production in alveolar macrophages by histogranin, a novel endogenous pentadecapeptide. Immunol Lett (1994) 0.78
Characterization of [125I][Ser1]histogranin binding sites in rat brain. J Pharmacol Exp Ther (1993) 0.78
Dynorphin potentiation of [3H]CGP-39653 binding to rat brain membranes. Eur J Pharmacol (1994) 0.78
Asbestos-induced fibrosis in rats: increase in lung mast cells and autacoid contents. Exp Lung Res (1987) 0.78
Distinct distribution of immunoreactive dynorphin and leucine enkephalin in various populations of isolated adrenal cromaffin cells. Life Sci (1983) 0.78
Synthesis and biological activity of analogs of dynorphin-A(1-13) substituted in positions 2 and 4: design of [Ala2,Trp4]-Dyn-A(1-13) as a putative selective opioid antagonist. Can J Physiol Pharmacol (1986) 0.78
Circadian regulation of the biosynthesis of cardiac Met-enkephalin and precursors in normotensive and spontaneously hypertensive rats. Life Sci (1991) 0.78
Dynorphin A-(1-13)-Tyr14-Leu15-Phe16-Asn17-Gly18-Pro19 : a potent and selective kappa opioid peptide. Eur J Pharmacol (1991) 0.77
Role of the sigma receptor in the inhibition of [3H]-noradrenaline uptake in brain synaptosomes and adrenal chromaffin cells. Br J Pharmacol (1991) 0.77
Selective involvement of kappa opioid and phencyclidine receptors in the analgesic and motor effects of dynorphin-A-(1-13)-Tyr-Leu-Phe-Asn-Gly-Pro. Brain Res (1992) 0.77
Changes in autacoid and neuropeptide contents of lung cells in asbestos-induced pulmonary fibrosis. Am Rev Respir Dis (1987) 0.77
Dynorphin in bovine adrenal medulla. I. Detection in glandular and cellular extracts and secretion from isolated chromaffin cells. Int J Pept Protein Res (1982) 0.77
Effect of enkephalin on the micturition cycle of the cat. Life Sci (1984) 0.77
Presence of sigma and phencyclidine (PCP)-like receptors in membrane preparations of bovine adrenal medulla. Biochem Pharmacol (1989) 0.77
Thymidine incorporation by lung fibroblasts as a sensitive assay for biological activity of asbestos. Environ Res (1982) 0.77
Characterization of (+)-[3H]3-PPP and [3H]TCP binding sites in membrane preparations of bovine adrenal medulla. Prog Clin Biol Res (1990) 0.77
Biochemical and histological responses in mussel (Mytilus edulis) exposed to North Sea oil and to a mixture of North Sea oil and alkylphenols. Mar Environ Res (2004) 0.77
Phorbol ester treatment of HL 60 leukemia cells results in increase of beta-(1 --> 4)-galactosyltransferase. Carbohydr Res (2000) 0.76
Somatostatin release from rat hypothalamus in vitro: effects of melatonin and serotonin. Endocrinology (1981) 0.76
Mass spectrometric identification of various molecular forms of dynorphin in bovine adrenal medulla. Biochem Biophys Res Commun (1982) 0.76
Acetylcholine, melatonin, and potassium depolarization stimulate release of luteinizing hormone-releasing hormone from rat hypothalamus in vitro. Proc Natl Acad Sci U S A (1982) 0.76
Increased content of immunoreactive Leu-enkephalin and alteration of delta-opioid receptor in hearts of spontaneously hypertensive rats. Neurosci Lett (1988) 0.76
Synthesis and biological activity of dynorphin-(1-13) and analogs substituted in positions 8 and 10. Int J Pept Protein Res (1986) 0.76
Synthesis and biological activity of beta-melanotropins and analogues. J Med Chem (1977) 0.76
Bombesin-like immunoreactivity in bovine adrenal medulla. Regul Pept (1986) 0.76
Central non-opioid physiological and pathophysiological effects of dynorphin A and related peptides. J Psychiatry Neurosci (1992) 0.76
Characterization of [3H]desmethylimipramine binding in bovine adrenal medulla: interactions with sigma- and (or) phencyclidine-receptor ligands. Can J Physiol Pharmacol (1992) 0.76
Norbinaltorphimine protection against N-methyl-D-aspartic acid-induced convulsions and mortality. Eur J Pharmacol (1993) 0.76
Assignment of 5-hydroxytryptamine receptor (HTR4) to human chromosome 5 bands q31-->q33 by in situ hybridization. Cytogenet Cell Genet (1997) 0.76
Synthesis and biological activity of histogranin and related peptides. Can J Physiol Pharmacol (1995) 0.76
Interactions of dynorphin A-(1-13) and nociceptin with cardiac D2 binding sites: inhibition of ischemia-evoked release of noradrenaline from synaptosomal-mitochondrial fractions. J Mol Cell Cardiol (2000) 0.75
Characterization of non-opioid [3H]dynorphin A-(1-13) binding sites in the rat heart. J Mol Cell Cardiol (1993) 0.75
Design of potent and selective dynorphin A related peptides devoid of supraspinal motor effects in mice. Can J Physiol Pharmacol (1993) 0.75
Alterations of heart dynorphin-A in the development of spontaneously hypertensive rats. Neuropeptides (1990) 0.75
Immunoreactive dynorphine in maternal blood, umbilical vein and amniotic fluid. Neuropeptides (1986) 0.75
Expression of the preproenkephalin A gene in the heart of cardiomyopathic hamsters. Biochem Cell Biol (1991) 0.75
Functional opioid receptor sites in human placentas. J Clin Endocrinol Metab (1988) 0.75
Neurobehavioral evidence for kappa agonist activity of the morphinan derivative 14-beta-methyl 8-oxacyclorphan [BC (3016)]. Pharmacol Biochem Behav (1991) 0.75
Identification, characterization, and photoaffinity labeling of the dihydropyridine receptor associated with the L-type calcium channel from bovine adrenal medulla. Mol Pharmacol (1990) 0.75
Non-opioid antinociceptive effects of supraspinal histogranin and related peptides: possible involvement of central dopamine D(2) receptor. Pharmacol Biochem Behav (2000) 0.75
Nonexocytotic noradrenaline release from rat cardiac synaptosomal-mitochondrial fractions. J Cardiovasc Pharmacol (1997) 0.75
Poly A-containing histone H4 mRNA variant (H4-v. 1): isolation and sequence determination from bovine adrenal medulla. Biochim Biophys Acta (1998) 0.75
Effects of chrysotile asbestos on DNA synthesis and growth of human embryonic lung fibroblasts. J Environ Pathol Toxicol Oncol (1987) 0.75
14-beta-Methyl-8-oxacyclorphan (BC-3016), a morphinan derivative with high affinity for kappa opioid receptor: comparison with dynorphin-A(1-13). Can J Physiol Pharmacol (1986) 0.75
Interaction of histogranin and related peptides with [3H]dextromethorphan binding sites in rat brain. Neurosci Lett (1994) 0.75
Adrenal dynorphin A and Leu-enkephalin levels in normotensive Wistar Kyoto (WKY) and spontaneously hypertensive rats (SHR). Prog Clin Biol Res (1990) 0.75
Design of potent dynorphin A-(1-9) analogues devoid of supraspinal motor effects in mice. Can J Physiol Pharmacol (1997) 0.75
In vivo opioid activity of S-methyl and S-allyl morphinan derivatives. Prog Clin Biol Res (1990) 0.75